New Product Development
The company actively pursues technical cooperation with national scientific research institutions. It jointly builds a high-end formulation achievement transformation base together with Shanghai Institute of Biomedical Technology, connecting the full industry-university-research chain of "basic research — pilot scale-up — industrialization". The company focuses on the R&D of new dosage forms such as sustained-release platforms, continuously enriches the product pipeline, accelerates the translation of new products from research to application, enhances international competitiveness, and is committed to fulfilling its corporate mission of "Dedicated to advancing reproductive health for women globally".
_1.png)
_1.png)
